| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | deaminase binding | 1.34e-04 | 4 | 95 | 2 | GO:1990827 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 2.14e-04 | 114 | 95 | 5 | GO:0004843 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 3.16e-04 | 124 | 95 | 5 | GO:0101005 | |
| GeneOntologyMolecularFunction | UDP-galactosyltransferase activity | 4.68e-04 | 32 | 95 | 3 | GO:0035250 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 4.99e-04 | 137 | 95 | 5 | GO:0019783 | |
| GeneOntologyMolecularFunction | galactosyltransferase activity | 6.11e-04 | 35 | 95 | 3 | GO:0008378 | |
| GeneOntologyMolecularFunction | O-acetyltransferase activity | 7.89e-04 | 9 | 95 | 2 | GO:0016413 | |
| Domain | HABP4_PAI-RBP1 | 1.28e-08 | 16 | 95 | 5 | PF04774 | |
| Domain | HABP4_PAIRBP1-bd | 1.28e-08 | 16 | 95 | 5 | IPR006861 | |
| Domain | IRO | 2.52e-06 | 6 | 95 | 3 | SM00548 | |
| Domain | Iroquois_homeo | 2.52e-06 | 6 | 95 | 3 | IPR003893 | |
| Domain | USP_CS | 2.14e-05 | 66 | 95 | 5 | IPR018200 | |
| Domain | USP_1 | 2.85e-05 | 70 | 95 | 5 | PS00972 | |
| Domain | UCH | 3.06e-05 | 71 | 95 | 5 | PF00443 | |
| Domain | USP_2 | 3.06e-05 | 71 | 95 | 5 | PS00973 | |
| Domain | USP_3 | 3.27e-05 | 72 | 95 | 5 | PS50235 | |
| Domain | USP_dom | 3.27e-05 | 72 | 95 | 5 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 3.27e-05 | 72 | 95 | 5 | IPR001394 | |
| Domain | Homeobox_KN | 8.23e-05 | 17 | 95 | 3 | PF05920 | |
| Domain | Homeobox_KN_domain | 8.23e-05 | 17 | 95 | 3 | IPR008422 | |
| Domain | PI3kinase_P85 | 2.53e-04 | 5 | 95 | 2 | IPR001720 | |
| Domain | hnRNP_C | 3.79e-04 | 6 | 95 | 2 | IPR017347 | |
| Pubmed | 3.39e-08 | 33 | 97 | 5 | 20228807 | ||
| Pubmed | 3.97e-08 | 34 | 97 | 5 | 20403174 | ||
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | 3.97e-08 | 34 | 97 | 5 | 14699124 | |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | 3.97e-08 | 34 | 97 | 5 | 15780755 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | 3.97e-08 | 34 | 97 | 5 | 19188362 | |
| Pubmed | 3.97e-08 | 34 | 97 | 5 | 11941478 | ||
| Pubmed | 3.97e-08 | 34 | 97 | 5 | 17109758 | ||
| Pubmed | 3.97e-08 | 34 | 97 | 5 | 20388806 | ||
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | 3.97e-08 | 34 | 97 | 5 | 20715989 | |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | 3.97e-08 | 34 | 97 | 5 | 9806828 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | 3.97e-08 | 34 | 97 | 5 | 20368735 | |
| Pubmed | 3.97e-08 | 34 | 97 | 5 | 10936051 | ||
| Pubmed | 3.97e-08 | 34 | 97 | 5 | 21448158 | ||
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | 4.62e-08 | 35 | 97 | 5 | 16611142 | |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | 4.62e-08 | 35 | 97 | 5 | 21239494 | |
| Pubmed | 5.35e-08 | 36 | 97 | 5 | 20147298 | ||
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | 6.18e-08 | 37 | 97 | 5 | 20228808 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | 3.28e-07 | 21 | 97 | 4 | 8622927 | |
| Pubmed | 3.28e-07 | 21 | 97 | 4 | 14583620 | ||
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | 3.28e-07 | 21 | 97 | 4 | 11468161 | |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | 3.28e-07 | 21 | 97 | 4 | 8756639 | |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | 3.28e-07 | 21 | 97 | 4 | 12447969 | |
| Pubmed | 3.28e-07 | 21 | 97 | 4 | 18980247 | ||
| Pubmed | 4.00e-07 | 22 | 97 | 4 | 9154835 | ||
| Pubmed | Comparison of Iroquois gene expression in limbs/fins of vertebrate embryos. | 4.18e-07 | 6 | 97 | 3 | 20408909 | |
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 11042145 | ||
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 36773339 | ||
| Pubmed | Regulated expression patterns of IRX-2, an Iroquois-class homeobox gene, in the human breast. | 4.18e-07 | 6 | 97 | 3 | 10370142 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | 5.79e-07 | 24 | 97 | 4 | 8995226 | |
| Pubmed | 6.87e-07 | 25 | 97 | 4 | 21115691 | ||
| Pubmed | The prepattern transcription factor Irx3 directs nephron segment identity. | 7.30e-07 | 7 | 97 | 3 | 17875669 | |
| Pubmed | 8.11e-07 | 26 | 97 | 4 | 35816173 | ||
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 11118473 | ||
| Pubmed | 1.28e-06 | 29 | 97 | 4 | 32527007 | ||
| Pubmed | 1.69e-06 | 31 | 97 | 4 | 27798109 | ||
| Pubmed | 1.75e-06 | 9 | 97 | 3 | 14585979 | ||
| Pubmed | Gene and cluster-specific expression of the Iroquois family members during mouse development. | 1.75e-06 | 9 | 97 | 3 | 11520674 | |
| Pubmed | Comparative influenza protein interactomes identify the role of plakophilin 2 in virus restriction. | 3.41e-06 | 11 | 97 | 3 | 28169297 | |
| Pubmed | 3.41e-06 | 11 | 97 | 3 | 10926765 | ||
| Pubmed | Interaction between nucleosome assembly protein 1-like family members. | 4.54e-06 | 12 | 97 | 3 | 21333655 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 25422958 | ||
| Pubmed | TCRP1 induces tamoxifen resistance by promoting the activation of SGK1 in MCF‑7 cells. | 7.70e-06 | 2 | 97 | 2 | 32323833 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 33568105 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 25640828 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26267381 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 23722113 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 25391453 | ||
| Pubmed | Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6. | 7.70e-06 | 2 | 97 | 2 | 27899381 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26923505 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20029939 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22018085 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 23717480 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 8.29e-06 | 258 | 97 | 7 | 37794589 | |
| Pubmed | Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein. | 8.48e-06 | 46 | 97 | 4 | 2649653 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 1.19e-05 | 50 | 97 | 4 | 31806660 | |
| Pubmed | Essential roles of mitochondrial biogenesis regulator Nrf1 in retinal development and homeostasis. | 1.28e-05 | 51 | 97 | 4 | 30333037 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 25422957 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 31361897 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23042660 | ||
| Pubmed | Linkage of Nat and Es-1 in the mouse and development of strains congenic for N-acetyltransferase. | 2.31e-05 | 3 | 97 | 2 | 3209851 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 10572050 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 9486539 | ||
| Pubmed | Plasminogen binds to disease-associated prion protein of multiple species. | 2.31e-05 | 3 | 97 | 2 | 11438139 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 26224810 | ||
| Pubmed | Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. | 2.31e-05 | 3 | 97 | 2 | 19081515 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 37392838 | ||
| Pubmed | Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse. | 2.32e-05 | 20 | 97 | 3 | 11245568 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 34380733 | ||
| Pubmed | Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. | 4.60e-05 | 4 | 97 | 2 | 19597492 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 29934252 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 25122764 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 23831410 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 15826941 | ||
| Pubmed | hnRNPC induces isoform shifts in miR-21-5p leading to cancer development. | 4.60e-05 | 4 | 97 | 2 | 35729324 | |
| Pubmed | The RNA-binding protein Staufen1 impairs myogenic differentiation via a c-myc-dependent mechanism. | 4.60e-05 | 4 | 97 | 2 | 25208565 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 36681355 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 12023960 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 22503102 | ||
| Pubmed | Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features. | 4.60e-05 | 4 | 97 | 2 | 19268543 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 10191262 | ||
| Pubmed | hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. | 4.60e-05 | 4 | 97 | 2 | 10805751 | |
| Pubmed | Cardiomyopathy in Irx4-deficient mice is preceded by abnormal ventricular gene expression. | 5.22e-05 | 26 | 97 | 3 | 11238910 | |
| Pubmed | 6.55e-05 | 28 | 97 | 3 | 32868762 | ||
| Pubmed | 7.18e-05 | 491 | 97 | 8 | 22623428 | ||
| Pubmed | Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. | 7.29e-05 | 29 | 97 | 3 | 15525990 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 12376544 | ||
| Pubmed | Iroquois genes influence proximo-distal morphogenesis during rat lung development. | 7.66e-05 | 5 | 97 | 2 | 16299054 | |
| Pubmed | Expression of two novel mouse Iroquois homeobox genes during neurogenesis. | 7.66e-05 | 5 | 97 | 2 | 10704856 | |
| Pubmed | Expression pattern of the homeodomain transcription factor Pitx2 during muscle development. | 7.66e-05 | 5 | 97 | 2 | 17166778 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 29846695 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 9128719 | ||
| Pubmed | Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism. | 7.66e-05 | 5 | 97 | 2 | 25809670 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 11335133 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 23233200 | ||
| Pubmed | COLGALT2 HNRNPCL3 SH3BP4 DOCK5 OSBPL3 SLC22A4 HNRNPCL4 CDC25B TASOR | 8.72e-05 | 650 | 97 | 9 | 38777146 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 8.74e-05 | 807 | 97 | 10 | 30575818 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 26048669 | ||
| Pubmed | Characterization of serotonin neurotransmission in knockout mice: implications for major depression. | 1.15e-04 | 6 | 97 | 2 | 23089640 | |
| Pubmed | Selective disruption of genes expressed in totipotent embryonal stem cells. | 1.15e-04 | 6 | 97 | 2 | 1317320 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 20816801 | ||
| Cytoband | 4p16.1 | 7.55e-07 | 79 | 97 | 5 | 4p16.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | 8.18e-06 | 222 | 97 | 6 | chr4p16 | |
| Cytoband | 13q12 | 1.18e-03 | 24 | 97 | 2 | 13q12 | |
| Cytoband | 19p13.3 | 1.65e-03 | 237 | 97 | 4 | 19p13.3 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 7.73e-05 | 26 | 58 | 3 | 526 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-06 | 168 | 94 | 6 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-06 | 168 | 94 | 6 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-06 | 196 | 94 | 6 | a2845436003e9adf34677eb81e78f8334ff01faa | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-06 | 196 | 94 | 6 | aa52f77f80c3fe23369347a34e0b3188b768a763 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.37e-05 | 144 | 94 | 5 | 6f1158c85e1d50ef6f2c67abdb2dc855a9786b9a | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.56e-05 | 148 | 94 | 5 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 153 | 94 | 5 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_large-bowel / Manually curated celltypes from each tissue | 2.71e-05 | 166 | 94 | 5 | 13bef304ea3df8e8d2bc376a3287c78220a1b0c6 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 2.87e-05 | 168 | 94 | 5 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 171 | 94 | 5 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.12e-05 | 171 | 94 | 5 | 87d652afbb375f8ee50e5faecf6085630cd2163c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.58e-05 | 176 | 94 | 5 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.68e-05 | 177 | 94 | 5 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.68e-05 | 177 | 94 | 5 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-05 | 177 | 94 | 5 | 3a85aa2bf3f2fdbea57d22d68e022cb3f6c2eb65 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 3.89e-05 | 179 | 94 | 5 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.89e-05 | 179 | 94 | 5 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.20e-05 | 182 | 94 | 5 | d1a1feef318062f25493355d7beee8e5fb0e4206 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 183 | 94 | 5 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 183 | 94 | 5 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.32e-05 | 183 | 94 | 5 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-05 | 183 | 94 | 5 | 2d0d3b486498a7903fa9a1f48b189291da49c430 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-05 | 183 | 94 | 5 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-05 | 183 | 94 | 5 | 06ac66726ec53db810ebb90ec69cfdb903da53f6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-05 | 184 | 94 | 5 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-05 | 184 | 94 | 5 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.54e-05 | 185 | 94 | 5 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.54e-05 | 185 | 94 | 5 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-05 | 186 | 94 | 5 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.78e-05 | 187 | 94 | 5 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.91e-05 | 188 | 94 | 5 | 7499e353ea5853d06558b20cedee3c7910425d7d | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.91e-05 | 188 | 94 | 5 | 562f5984efdbbcb8f53ddcee033ccbf9eb678425 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.03e-05 | 189 | 94 | 5 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | PND07-Epithelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 190 | 94 | 5 | e3a2c8b637f60c963520dffe99c526809d818cab | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.16e-05 | 190 | 94 | 5 | 6b704deeb44e1ffa10e604d0e5612b022f6cd9a6 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 5.42e-05 | 192 | 94 | 5 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.42e-05 | 192 | 94 | 5 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 193 | 94 | 5 | 22ebc3f586eb0aabc5785e468c88d7416c624ff4 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-05 | 194 | 94 | 5 | 0ef63abcfd057079a9a6f8b27404ff521d44845d | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.83e-05 | 195 | 94 | 5 | fc75f04eb475c8139cc5c35e6be22e73fb2be9e6 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.83e-05 | 195 | 94 | 5 | 83d45ff5e5bc704448431149fffb2e4c1278f279 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.27e-05 | 198 | 94 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.27e-05 | 198 | 94 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_3|COVID-19_Severe / Disease condition and Cell class | 6.42e-05 | 199 | 94 | 5 | ffb2ef9b7006cbed0f43637af040719b9776cbd5 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | eac33be484dc443794e66e473f03e98406c2983e | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-05 | 105 | 94 | 4 | 8f31edf4183587f5b53941475453c5aa49f10bbd | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-04 | 125 | 94 | 4 | 5626eb77e542fcc87cd1fdf65f8623f3249ff9db | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 132 | 94 | 4 | c6bf0b4b9e33b517629faf4559a21d7ba720ee6a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 142 | 94 | 4 | 58c2882cb0ede8cc5d84c85a650d28267268e748 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 146 | 94 | 4 | d903e091a917d3f5dcf82107e636520f75e47403 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 146 | 94 | 4 | 9c9218e5257253597f2fd74fbd589b962d3078a3 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Reln_(Neuron.Gad1Gad2.Cplx3-Reln)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.91e-04 | 61 | 94 | 3 | 06aab3f1743ced1e46d22f0310f1cdb70c7a108e | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Reln_(Neuron.Gad1Gad2.Cplx3-Reln)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.91e-04 | 61 | 94 | 3 | fec6c9a4e12c260338856567bf547f914f473dbb | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.17e-04 | 154 | 94 | 4 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.33e-04 | 156 | 94 | 4 | 5b2781d38a83b4b0f8a53cf321ce5db3a07d0818 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 156 | 94 | 4 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.33e-04 | 156 | 94 | 4 | e0aef6104be16b12304b8e30358f444c1660e92f | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 157 | 94 | 4 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 157 | 94 | 4 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 157 | 94 | 4 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 157 | 94 | 4 | b6ecf1d8c6a465ff31cbc181e00ea88b76b38e19 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 157 | 94 | 4 | 01ad5cbaf91010e79216e1fb37b7b890618c5f28 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-MAIT|Bac-SEP / Disease, Lineage and Cell Type | 3.58e-04 | 159 | 94 | 4 | e043c65f3febdfa7f75a67702e92fcdebe144a00 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-04 | 159 | 94 | 4 | 5c7a099aa84ecc62bf9b5e1609e5b6b77889f175 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-04 | 162 | 94 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-04 | 163 | 94 | 4 | 1eec7f5e5fed05fa21d3f81db588f10605f08ea7 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.93e-04 | 163 | 94 | 4 | 476e94e1d132eaaecb9e376bd32748a75ad22081 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-04 | 164 | 94 | 4 | 4ade97931ae1780af7836d988fe117a10b3e88a1 | |
| ToppCell | C_02|World / shred on cell type and cluster | 4.11e-04 | 165 | 94 | 4 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.11e-04 | 165 | 94 | 4 | 0c80abf13409767825ef8a507b498afafa7e89c5 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.11e-04 | 165 | 94 | 4 | cced77f2d74b07010307d7f4788b8cf3fdaeb91a | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.31e-04 | 167 | 94 | 4 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.31e-04 | 167 | 94 | 4 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-04 | 168 | 94 | 4 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.40e-04 | 168 | 94 | 4 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.50e-04 | 169 | 94 | 4 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.50e-04 | 169 | 94 | 4 | 29db25e7c5f31d98a08a35d7ec5ade203242bc50 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.50e-04 | 169 | 94 | 4 | b1611e61f635f8f9b87250e026ad30999cbee041 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.60e-04 | 170 | 94 | 4 | 6c0619cbe2f01a6de18da0a137f92bda0cbdf075 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.60e-04 | 170 | 94 | 4 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.60e-04 | 170 | 94 | 4 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-04 | 171 | 94 | 4 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-2_VIP_RPL41P3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.71e-04 | 171 | 94 | 4 | f6047dee2be0b09ad4d48f97369111bc92e89b35 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-04 | 172 | 94 | 4 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.92e-04 | 173 | 94 | 4 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.13e-04 | 175 | 94 | 4 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.13e-04 | 175 | 94 | 4 | 8a4ed775ff973123dbcfe9c809959d11a62450c9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-04 | 175 | 94 | 4 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Cbln1_(Layer_5a,_entorhinal_cortex_,_Cbln1+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.14e-04 | 74 | 94 | 3 | 0be24b07a2503a16ece1489e765200be4c7253cc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-04 | 177 | 94 | 4 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-04 | 177 | 94 | 4 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 5.36e-04 | 177 | 94 | 4 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.47e-04 | 178 | 94 | 4 | 4b3ea0921bc598ebb9f63780ecdf8ad4349f3666 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.59e-04 | 179 | 94 | 4 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-04 | 179 | 94 | 4 | 9fd9b136ecbcbd4e4f0d5875ede98d8d48608afb | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.59e-04 | 179 | 94 | 4 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-04 | 179 | 94 | 4 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.59e-04 | 179 | 94 | 4 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-04 | 179 | 94 | 4 | 2285e3a9018a60d7f6e974fee46b6f61d39aa76f | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-04 | 179 | 94 | 4 | 0b0f27d7c5cc5ae7618d887dcfa7219df8ff1935 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | 2.77e-07 | 46 | 89 | 5 | DOID:5426 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.15e-06 | 69 | 89 | 5 | DOID:1682 (implicated_via_orthology) | |
| Disease | serum metabolite measurement | NAT2 STK32B CPT1A ABCA7 KMO FAAH SH3BP4 SLC22A4 DEF6 PAH PCDH15 ZFHX3 | 2.68e-05 | 945 | 89 | 12 | EFO_0005653 |
| Disease | Ischemic stroke, cardiac embolism | 2.69e-05 | 3 | 89 | 2 | EFO_1001493, HP_0002140 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 3.39e-05 | 21 | 89 | 3 | EFO_0022262 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 9.35e-05 | 150 | 89 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 1.02e-04 | 30 | 89 | 3 | EFO_0004629, HP_0002140 | |
| Disease | atherosclerosis (is_marker_for) | 1.91e-04 | 37 | 89 | 3 | DOID:1936 (is_marker_for) | |
| Disease | QT interval | 2.14e-04 | 534 | 89 | 8 | EFO_0004682 | |
| Disease | degree of unsaturation measurement | 2.24e-04 | 39 | 89 | 3 | EFO_0022261 | |
| Disease | docosahexaenoic acid measurement, fatty acid measurement | 2.42e-04 | 40 | 89 | 3 | EFO_0005110, EFO_0007761 | |
| Disease | sick sinus syndrome | 2.49e-04 | 8 | 89 | 2 | MONDO_0001823 | |
| Disease | familial sick sinus syndrome | 2.49e-04 | 8 | 89 | 2 | MONDO_0012061 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.56e-04 | 291 | 89 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | nervonoylcarnitine (C24:1) measurement | 3.19e-04 | 9 | 89 | 2 | EFO_0800549 | |
| Disease | Parkinson's disease symptom measurement | 4.16e-04 | 48 | 89 | 3 | EFO_0600011 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 4.69e-04 | 50 | 89 | 3 | EFO_0022303 | |
| Disease | lignoceroylcarnitine (C24) measurement | 4.86e-04 | 11 | 89 | 2 | EFO_0800541 | |
| Disease | sexual dimorphism measurement | ATXN2L CWH43 VGLL2 COLGALT2 HNRNPC SLC6A4 LPA DEF6 ZFHX3 TASOR PRNP | 4.92e-04 | 1106 | 89 | 11 | EFO_0021796 |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 4.97e-04 | 51 | 89 | 3 | EFO_0022302 | |
| Disease | arachidonoylcarnitine (C20:4) measurement | 5.82e-04 | 12 | 89 | 2 | EFO_0800544 | |
| Disease | Acute Cerebrovascular Accidents | 5.89e-04 | 54 | 89 | 3 | C0751956 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 6.02e-04 | 127 | 89 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | Cocaine Abuse | 6.02e-04 | 127 | 89 | 4 | C0009171 | |
| Disease | Antithrombotic agent use measurement | 6.21e-04 | 55 | 89 | 3 | EFO_0009925 | |
| Disease | von Willebrand factor measurement | 6.55e-04 | 56 | 89 | 3 | EFO_0004629 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 6.87e-04 | 13 | 89 | 2 | EFO_0800547 | |
| Disease | cerotoylcarnitine (C26) measurement | 6.87e-04 | 13 | 89 | 2 | EFO_0800542 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 7.98e-04 | 239 | 89 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | Cerebrovascular accident | 8.82e-04 | 62 | 89 | 3 | C0038454 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 9.24e-04 | 63 | 89 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 9.63e-04 | 144 | 89 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | electrocardiography | 1.12e-03 | 530 | 89 | 7 | EFO_0004327 | |
| Disease | sphingomyelin 14:0 measurement | 1.19e-03 | 17 | 89 | 2 | EFO_0010390 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 1.19e-03 | 17 | 89 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 1.19e-03 | 17 | 89 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 1.19e-03 | 17 | 89 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 1.19e-03 | 17 | 89 | 2 | C0751780 | |
| Disease | May-White Syndrome | 1.19e-03 | 17 | 89 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 1.19e-03 | 17 | 89 | 2 | C0751781 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.21e-03 | 153 | 89 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 1.33e-03 | 18 | 89 | 2 | C0751779 | |
| Disease | factor VIII measurement, Ischemic stroke | 1.49e-03 | 19 | 89 | 2 | EFO_0004630, HP_0002140 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 1.71e-03 | 78 | 89 | 3 | EFO_0022187 | |
| Disease | trauma exposure measurement | 1.85e-03 | 172 | 89 | 4 | EFO_0010703 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.27e-03 | 86 | 89 | 3 | EFO_0008595, EFO_0020945 | |
| Disease | Anhedonia | 2.38e-03 | 24 | 89 | 2 | C0178417 | |
| Disease | Involutional paraphrenia | 2.58e-03 | 25 | 89 | 2 | C1571983 | |
| Disease | Psychosis, Involutional | 2.58e-03 | 25 | 89 | 2 | C1571984 | |
| Disease | Involutional Depression | 2.58e-03 | 25 | 89 | 2 | C0011574 | |
| Disease | Prostatic Neoplasms | 2.63e-03 | 616 | 89 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.63e-03 | 616 | 89 | 7 | C0376358 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 3.01e-03 | 95 | 89 | 3 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 3.01e-03 | 27 | 89 | 2 | EFO_0004629, EFO_0004630 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GAPTYMYEFQYRPSF | 441 | P23141 | |
| MNKFGYSLPYPQYFG | 221 | O60512 | |
| YQSMIRPPYSSYGYE | 56 | Q99218 | |
| PFYIVTEYMPYGNLL | 356 | P42684 | |
| YLRGRGPLMVNSNYY | 241 | P50416 | |
| RQDGGPPYYMIETYK | 446 | Q9NU02 | |
| YSPQYISYIPQIHMG | 706 | Q8WWM7 | |
| GLYLQQMPYPCYVDD | 526 | Q8IZY2 | |
| QLFMNYTAYYPSPPG | 596 | Q6NXG1 | |
| LYYRYMNPAIVAPDA | 1191 | P46940 | |
| YTQSYPMRNPTDSLY | 201 | O95980 | |
| EPALGQYPYDRYGTM | 126 | P78413 | |
| PCIPQRDMFYNGLYY | 576 | Q6IE37 | |
| RDMFYNGLYYTPVSN | 581 | Q6IE37 | |
| VFNIQPAPAMVYDYY | 1161 | Q6IE37 | |
| PAPAMVYDYYEKGRQ | 1166 | Q6IE37 | |
| DGPLYQSYPMVLQYR | 236 | Q86SE9 | |
| DYYDRMYSYPARVPP | 131 | P07910 | |
| MPTYRAQGTPAYSYV | 226 | Q92567 | |
| PIYGMFTYYQDSNLL | 761 | Q15034 | |
| NRLDLPPYPSYSMLY | 1576 | Q76N89 | |
| QRDYYGGMYSFPARV | 116 | B7ZW38 | |
| PFYRRHTPYMVQPEY | 16 | O43679 | |
| YIYFLFPPLMNPVIY | 276 | Q9Y5P1 | |
| YAYFLFPPLMNPITY | 276 | Q9H339 | |
| FYGTIIYMYLQPGNR | 251 | Q9Y3N9 | |
| PGADMQRSYDSYYYP | 666 | O14511 | |
| PYYMSPERIHENGYN | 211 | Q9HC98 | |
| RAVNDYPSLYYPEMY | 506 | P30305 | |
| QRDYYGGMYSFPARV | 116 | P0DMR1 | |
| YRPEMYQYSLPRPAY | 1611 | Q6ZVL6 | |
| QVPYMCPDYQSYFRT | 136 | Q92764 | |
| SLLGDIPPSNNYYMY | 276 | Q9P0K8 | |
| IPQRDMFYNGLYYTP | 626 | Q6IE36 | |
| MSYPQGYLYQAPGSL | 1 | Q9BZI1 | |
| YNYRHGQPIPRVEYM | 166 | P00439 | |
| YLPAIYMYLQPPSSY | 256 | Q5JQS5 | |
| YMYLQPPSSYSQEQG | 261 | Q5JQS5 | |
| MAGPEGFQYRALYPF | 1 | O00459 | |
| QMEQPTLAFYVGYYL | 276 | Q969V1 | |
| QSPYFTMPSYQGYIL | 391 | Q96QU1 | |
| PYEGQRSYLVQYMQF | 806 | Q92900 | |
| NYFTGYLMRGYAPNR | 276 | O43825 | |
| PRFDYSQQYIPHGYM | 181 | O15229 | |
| IVMDRPYQFYYFVPL | 506 | Q96PB1 | |
| MRPQPEYFAVGYYGQ | 1356 | Q9H7D0 | |
| RLYYLGMPYGSRENS | 71 | Q86TI2 | |
| RTPEYYPNAGLIMNY | 176 | P08519 | |
| PEYYPNAGLIMNYCR | 406 | P08519 | |
| YYPNAGLIMNYCRNP | 636 | P08519 | |
| RTPEYYPNAGLIMNY | 746 | P08519 | |
| KRPGVYTDYIYQGPM | 291 | P34998 | |
| GPVSSQGYMPYLNKY | 61 | Q9H4E7 | |
| GYFYIPPVNKYSTGM | 91 | P11245 | |
| RVGYYETDNYTMPSP | 326 | O00519 | |
| MYLCNREHYGYLPIP | 281 | Q8IYK4 | |
| GEYTMEYSRYQPCLP | 711 | Q96RP9 | |
| YPRLYPELSQYMGLS | 46 | O00560 | |
| PYFVYLGAYNRMLPY | 476 | Q9H015 | |
| KDMAPYQGPALYVYN | 146 | Q9NZJ4 | |
| DPMNVFYPGEYVGYL | 4171 | Q9NZJ4 | |
| YLFQYPVRPASMTYD | 26 | Q9NVU0 | |
| LGMEVPYYYFTRKPE | 721 | Q96RY7 | |
| LYQGKMYFPGYFPNE | 91 | Q1ZYL8 | |
| MYFPGYFPNELRNIF | 96 | Q1ZYL8 | |
| PYTNCYAQRYYPMPE | 36 | Q96KJ9 | |
| YMRPVYPTKTFPNLY | 201 | Q13822 | |
| RANPMPKGYEQYYSF | 771 | Q9H4L5 | |
| MSFPQLGYQYIRPLY | 1 | P78415 | |
| LYHDLGPMIYYFPLQ | 21 | Q9H720 | |
| GPPIENGFYYDMYLE | 176 | P26639 | |
| MGYIPSSYVQPLNYR | 101 | Q9P0V3 | |
| YYPGFNPFRAYMNLD | 1571 | A2VDJ0 | |
| YNSAMNPLIYALFYP | 301 | Q969N4 | |
| VYNPFYMYQHISPDL | 126 | Q8N9U0 | |
| QYQPSLRRDPMYNEY | 261 | Q7L5D6 | |
| AIRTAYTYNPEPQMY | 86 | P48378 | |
| YFVTFPYPYMNGRLH | 46 | Q9P2J5 | |
| QYELYNPMALYGSVP | 286 | Q14697 | |
| PEFYYLPEMFVNSNG | 2436 | Q8NFP9 | |
| VLYEMLYGLPPFYSR | 286 | O00141 | |
| TMLSVGYYRNIYTPP | 1926 | Q9UKZ4 | |
| NGLMQPYDDMYPGYS | 161 | Q99697 | |
| GYLFLLSPYQMVPPY | 466 | Q9UK61 | |
| YLMVPYYPRANLNAV | 806 | Q9BXU1 | |
| VMYQVYGPPQPYFAA | 6 | Q8N8G2 | |
| STYNYNMRGGAYPPR | 101 | O95793 | |
| YASFMVPGYLLVQYF | 46 | Q8TB61 | |
| DYGMLPAQIIEYYNP | 326 | Q9UPY6 | |
| YMSQPNTGPLVYVLY | 306 | A8MUK1 | |
| YMSQPNTGPLVYVLY | 306 | D6R901 | |
| RYPNQVYYRPMDEYS | 156 | P04156 | |
| QMPDYSIFRGYIIQY | 1146 | Q8WWQ8 | |
| PYRAMYQYRPQNEDE | 616 | O60504 | |
| AYPPELRFMYYVDGR | 186 | P58753 | |
| VNIFMEYYRKFPPGV | 1146 | Q8N9V7 | |
| YMSQPNTGPLVYVLY | 306 | C9JPN9 | |
| YMSQPNTGPLVYVLY | 306 | Q0WX57 | |
| YPEPRNINIYTYDDM | 26 | Q93045 | |
| VFQVYMDRGPGYSYP | 191 | Q9NY57 | |
| FLMSPPQLRLFQYNY | 556 | P31645 | |
| MNLGYYGQYPAPLYL | 1061 | Q9Y6X0 | |
| YMSQPNTGPLVYVLY | 306 | D6RJB6 | |
| YPFGMYIPFLQLNCD | 196 | Q9GZU3 | |
| YLQPMYGMEGLFPYS | 3331 | Q15911 | |
| NRMYKLYPSEYNIFP | 161 | A6NNM8 | |
| MELYETSPYFYQEPR | 1 | P15173 |